Vertex Pharmaceuticals (Europe) Limited
GPTKB entity
Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:countryOfOrigin |
gptkb:United_Kingdom
|
| gptkbp:focusesOn |
rare diseases
cystic fibrosis treatments |
| gptkbp:headquartersLocation |
gptkb:United_Kingdom
|
| https://www.w3.org/2000/01/rdf-schema#label |
Vertex Pharmaceuticals (Europe) Limited
|
| gptkbp:industry |
gptkb:biotechnology
pharmaceuticals |
| gptkbp:operatesIn |
gptkb:Europe
|
| gptkbp:parentCompany |
gptkb:Vertex_Pharmaceuticals
|
| gptkbp:subsidiary |
gptkb:Vertex_Pharmaceuticals
|
| gptkbp:bfsParent |
gptkb:Vertex_Pharmaceuticals_Incorporated
|
| gptkbp:bfsLayer |
7
|